Exons 1 and 2 were targeted with gRNAs using CRISPR/Cas9 technology. This allele represents line #14 which has a 8 bp deletion in exon 2. Western blotting using protein extracts from thymus, spleen and MEFs showed the lack of expression from this allele. (J:274050)